Last reviewed · How we verify

NCT02939404

Food Intake Response to Short-Term Modifications of Metabolism in Humans

Completed NA Results posted Last updated 4 July 2025
What this trial tests

NA trial testing Cold exposure in Healthy Volunteers in 54 participants. Completed in 24 June 2024.

Timeline
27 April 2017
Primary endpoint
24 June 2024
24 June 2024

Quick facts

Lead sponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment54
Start date27 April 2017
Primary completion24 June 2024
Estimated completion24 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Who can join

Adults 18 to 55, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

24-hour Energy Expenditure (kcal) Primary · Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)

Energy expenditure (EE) as measured during 24 hours in a whole-room calorimeter

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First2256± 393
2. Chamber at 19°C, ad Libitum Diet First2166± 302
Chamber at 24°C, ad libitum diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First2563± 422
2. Chamber at 19°C, ad Libitum Diet First2487± 385
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First2271± 360
2. Chamber at 19°C, ad Libitum Diet First2153± 304
Chamber at 19°C, ad libitum diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First2552± 418
2. Chamber at 19°C, ad Libitum Diet First2505± 401
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First2135± 337
2. Chamber at 19°C, ad Libitum Diet First1998± 296
24-hour Energy Intake (kcal) Primary · Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)

Energy intake as measured during 24 hours in a whole-room calorimeter

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First3811± 1140
2. Chamber at 19°C, ad Libitum Diet First3694± 1503
Chamber at 24°C, ad libitum diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First4091± 1054
2. Chamber at 19°C, ad Libitum Diet First4359± 1404
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First4014± 1136
2. Chamber at 19°C, ad Libitum Diet First4075± 1587
Chamber at 19°C, ad libitum diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First4509± 1255
2. Chamber at 19°C, ad Libitum Diet First4762± 1610
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First3795± 1223
2. Chamber at 19°C, ad Libitum Diet First4112± 1406
24- Hour Respiratory Quotient (RQ) Secondary · Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)

RQ, an approximation for the ratio of carbohydrate-to-fat oxidation rates, is measured while in the chamber

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.868± 0.024
2. Chamber at 19°C, ad Libitum Diet First0.868± 0.029
Chamber at 24°C, ad libitum diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.925± 0.056
2. Chamber at 19°C, ad Libitum Diet First0.935± 0.06
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.872± 0.02
2. Chamber at 19°C, ad Libitum Diet First0.867± 0.032
Chamber at 19°C, ad libitum diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.909± 0.037
2. Chamber at 19°C, ad Libitum Diet First0.916± 0.045
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.793± 0.022
2. Chamber at 19°C, ad Libitum Diet First0.789± 0.03
Leptin Secondary · Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)

Plasma leptin (ng/ml)

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First26.1± 26.4
2. Chamber at 19°C, ad Libitum Diet First26.5± 30.5
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First29.5± 30.1
2. Chamber at 19°C, ad Libitum Diet First27.8± 30.3
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First18.3± 19.9
2. Chamber at 19°C, ad Libitum Diet First16.6± 22.1
Secretin Secondary · Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)

Plasma secretin (ng/ml)

(Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.91± 0.22
2. Chamber at 19°C, ad Libitum Diet First0.91± 0.25
(Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First1.03± 0.26
2. Chamber at 19°C, ad Libitum Diet First1.00± 0.25
(Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.99± 0.24
2. Chamber at 19°C, ad Libitum Diet First1.01± 0.24
Ghrelin Secondary · Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)

Plasma grehlin (pg/ml)

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First502± 254
2. Chamber at 19°C, ad Libitum Diet First644± 274
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First544± 277
2. Chamber at 19°C, ad Libitum Diet First605± 311
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First575± 293
2. Chamber at 19°C, ad Libitum Diet First581± 304
FGF-21 Secondary · Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)

Plasma FGF-21 (pg/ml)

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First94± 73
2. Chamber at 19°C, ad Libitum Diet First98± 72
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First98± 81
2. Chamber at 19°C, ad Libitum Diet First113± 90
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First106± 66
2. Chamber at 19°C, ad Libitum Diet First108± 76
Core Body Temperature (C) Secondary · Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)

Core body temperature measured in chamber

Chamber at 24°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First36.98± 0.15
2. Chamber at 19°C, ad Libitum Diet First37.02± 0.17
Chamber at 19°C, fixed diet
GroupValue95% CI
Chamber at 19°C With Fixed Diet First36.97± 0.19
2. Chamber at 19°C, ad Libitum Diet First36.95± 0.20
Chamber at 24°C, fasting
GroupValue95% CI
Chamber at 19°C With Fixed Diet First36.98± 0.21
2. Chamber at 19°C, ad Libitum Diet First36.98± 0.21
Weight Change at 6 Months Secondary · 6 months

Weight change from baseline to 6 months

GroupValue95% CI
Chamber at 19°C With Fixed Diet First0.3± 5.6
2. Chamber at 19°C, ad Libitum Diet First-0.5± 8.1
Weight Change at 12 Months Secondary · 12 months

Weight change from baseline to 12 months

GroupValue95% CI
Chamber at 19°C With Fixed Diet First1.0± 8.9
2. Chamber at 19°C, ad Libitum Diet First-0.6± 8.9

Adverse events — posted to ClinicalTrials.gov

Time frame: 1 year. Reporting threshold: 1%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Chamber at 19°C With Fixed Diet First
Serious: 0/24 (0%)
Deaths: 0/24
2. Chamber at 19°C, ad Libitum Diet First
Serious: 0/30 (0%)
Deaths: 0/30
Other adverse events (2 terms — click to expand)

ReactionSystemChamber at 19°C With Fixed…2. Chamber at 19°C, ad Lib…
Gastroesophageal reflux disease symptoms at Chamber at 24°C, fixed dietGastrointestinal disorders
Gastroesophageal reflux disease symptoms at Chamber at 19°C, fixed dietGastrointestinal disorders

Data from ClinicalTrials.gov NCT02939404 adverse events section.

Sponsor's own description

One reason people gain weight is eating more calories from food than what they need for energy over 24 hours. Metabolism is the amount of energy a person uses over 24 hours. Researchers want to study the relationship between changes in metabolism and how much a person eats. Objectives: To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats. Eligibility: Healthy people ages 18-55. Design: Participants will stay at NIH for 20 days. During the first 4 days, participants will have: * Medical exam * Electrocardiogram * Blood and urine tests. One blood test includes drinking a sugar solution. * DXA body composition scan * Questions about foods they like, physical activity, and personal behavior * Exercise test on a stationary bicycle Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler. Some times, participants will eat a diet that matches their daily needs (fixed or eucaloric). Other times, they can eat as much as they wish from a vending machine (ad libitum). Participants will have blood and urine collected. Participants will swallow an ingestible wireless sensor and wear a small data recorder device. On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages. Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Metabolic Responses to 24-Hour Fasting and Mild Cold Exposure in Overweight Individuals Are Correlated and Accompanied by Changes in FGF21 Concentration.
    Hollstein T, Heinitz S, Ando T, Rodzevik TL, et al · · 2020 · cited 17× · PMID 32341039 · DOI 10.2337/db20-0153
  2. Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes.
    Hollstein T, Basolo A, Ando T, Votruba SB, et al · · 2020 · cited 16× · PMID 32118268 · DOI 10.1210/clinem/dgaa098
  3. Impaired metabolic flexibility to fasting is associated with increased ad libitum energy intake in healthy adults.
    Unlu Y, Piaggi P, Stinson EJ, Cabeza De Baca T, et al · · 2024 · cited 5× · PMID 38650517 · DOI 10.1002/oby.24011
  4. Cold induces increased ad libitum energy intake independent of changes in energy expenditure: a controlled crossover trial in adults.
    Unlu Y, Piaggi P, Stinson EJ, De Baca TC, et al · · 2025 · cited 1× · PMID 39675563 · DOI 10.1016/j.ajcnut.2024.12.013
  5. Hunger on the Three-Factor Eating Questionnaire Is Associated With Increased Ad Libitum Energy Intake in Different Conditions.
    Fry HT, Gluck ME, de Baca TC, Stinson EJ, et al · · 2026 · PMID 41709501 · DOI 10.1002/oby.70148

Verify or expand the search:

Other trials of Cold exposure

Trials testing the same drug.

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

Other National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02939404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing